Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07035418

Adolescents and Young Adults With Cancer: Their Preferred Involvement in Decision Making

The purpose of this mixed-methods study is to determine Adolescent and Young Adult (AYAs) decision making preferences post cancer diagnosis using vignettes designed to assess their preferred involvement in decisions about their cancer treatment and variables associated with these treatment decision-making (TDM) preferences.

Recruiting

Interested in participating?

Request Info

Key information

Age range

15 year–29 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Stanford University

Palo Alto, California, 94304, United States

Location status: Recruiting

Location contact

Kimberly Pyke-Grimm

PRINCIPAL_INVESTIGATOR

Swathi Alagandula

CONTACT

[email protected]

650-725-1976

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age (15-29 years)
  • Cancer diagnosis and on therapy, end-of-life or survivors (within 1 year)
  • Speaks English
  • Reads English
  • Cognitively and physically able to participate

Exclusion criteria

  • Unable to participate in study due to developmental delay or developmental disorder

Treatment and study plan

Clinical Decision-Making Scenarios and Preferences Assessment

Behavioral

Participants complete a socio-demographic questionnaire and decision-making preferences scale, including hypothetical clinical scenarios, to identify their preferred decision-making role (active, collaborative, or passive) and the influence of providers or family. Delivered electronically via secure link; reminders sent as needed.

Primary outcomes

  1. Distribution of Decision-Making Roles in Clinical Scenarios

    Time frame: Within 2 weeks of survey link delivery

    Proportion of participants who select an active, collaborative, or passive role in hypothetical clinical decision-making scenarios. Each role will be counted and compared across participant subgroups.

Secondary outcomes

  1. Association Between Sociodemographic Characteristics and Decision-Making Role

    Time frame: At time of electronic survey completion

    This outcome assesses the association between sociodemographic characteristics (e.g., age, race/ethnicity, gender, education level, and employment status) and adolescents' and young adults' preferred treatment decision-making role. Role preference (active, collaborative, or passive) is assessed using the modified Control Preferences Scale. Sociodemographic variables are self-reported via electronic questionnaire. The unit of measure is the chi-square test statistic or ANOVA output, depending on the variable type.

  2. Concordance Between Interview Responses and Scenario-Based Decision-Making Roles

    Time frame: At time of interview, within 4 weeks of survey completion

    Proportion of interview responses that align with or differ from role preferences identified in hypothetical scenarios. Qualitative responses will be coded and categorized into roles for comparison.

  3. Correlation Between Healthcare Encounters and Decision-Making Role Preference

    Time frame: At time of interview, within 4 weeks of survey completion

    This outcome measures the correlation between the number of cancer-related healthcare encounters and adolescents' and young adults' preferred treatment decision-making role. Healthcare encounters will be abstracted from the electronic health record and include clinic visits, procedures, hospitalizations, ICU stays, and emergency department visits. Decision-making role preference (active, collaborative, or passive) will be assessed using the modified Control Preferences Scale. The unit of measure is the Pearson correlation coefficient.

Study contacts

Contact information is provided by the study sponsor or research team.

Swathi Alagandula

CONTACT

[email protected]

650-725-1976

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Registry information

Important dates

Study start
2022
Primary completion
2026
Study completion
2026
First posted
Jun 25, 2025
Registry last updated
Feb 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.